See also this year's filing and all EDGAR filings for this company.
PDF Report 0001347178_2023_Vanda_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001347178, Vanda Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 519,292,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 18,565,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,573,000 |
| 3 | remainder_Assets | 93,817,000 |
| 4 | LiabilitiesCurrent | 91,436,000 |
| 5 | LiabilitiesNoncurrent | 15,613,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 136,485,000 |
| 9 | ResearchAndDevelopmentExpense | 85,770,000 |
| 10 | remainder_Expenses | 30,823,000 |
| 11 | remainder_Revenues | 259,353,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -1,018,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 634,247,000 |
| 1 | Liabilities | 107,049,000 |
| 2 | Expenses | 253,078,000 |
| 3 | Revenues | 259,353,000 |
| 4 | StockholdersEquity | 527,198,000 |
| 5 | NetIncome | 6,275,000 |
| 6 | ComprehensiveNetIncome | 5,766,000 |
| 7 | BaseVar | 627,372,500 |
| 8 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
